Please wait while the formulary information is being retrieved.
VIGAMOX (MOXIFLOXACIN HCL)
- Bacterial conjunctivitis
0.5 % eye drops
- Instill 1 drop into affected eye(s) by ophthalmic route 3 times per day
0.5 % eye drops
- Instill 1 drop into affected eye(s) by ophthalmic route 3 times per day
Bacterial conjunctivitis
- Instill 1 drop into left eye by ophthalmic route 3 times per day
- Instill 1 drop into right eye by ophthalmic route 3 times per day
- Instill 1 drop into both eyes by ophthalmic route 3 times per day
- Instill 1 drop into left eye by ophthalmic route 3 times per day for 7 days
- Instill 1 drop into right eye by ophthalmic route 3 times per day for7 days
- Instill 1 drop into both eyes by ophthalmic route 3 times per day for7 days
- Instill 1 drop into affected eye(s) by ophthalmic route 3 times per day for 7 days
- Instill 1 drop into affected eye(s) by ophthalmic route 3 times per day
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
VIGAMOX (MOXIFLOXACIN HCL)
- Bacterial conjunctivitis
- None
- Eye tearing
More Frequent
Severe
Less Severe
- Conjunctival hyperemia
- Conjunctivitis
- Keratitis
- Ocular itching
- Reduced visual acuity
- Subconjunctival hemorrhage
- Dry eye
- Ocular discomfort
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute bacterial otitis media
- Cough
- Fever
- Hypersensitivity drug reaction
- Infection
- Ocular pain
- Skin rash
Less Severe
- Pharyngitis
- Rhinitis
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Moxifloxacin
- Severity Level:
2
- Additional Notes: Insuff human data; animal data sug dev tox at doses <2.5 x mrhd
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Moxifloxacin (ophth)
Amount of systemic absorption unknown, caution advised.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Amount of systemic absorption unknown, caution advised. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Bacterial conjunctivitis | |
| H10.02 | Other mucopurulent conjunctivitis |
| H10.021 | Other mucopurulent conjunctivitis, right eye |
| H10.022 | Other mucopurulent conjunctivitis, left eye |
| H10.023 | Other mucopurulent conjunctivitis, bilateral |
| H10.029 | Other mucopurulent conjunctivitis, unspecified eye |
| H10.3 | Unspecified acute conjunctivitis |
| H10.30 | Unspecified acute conjunctivitis, unspecified eye |
| H10.31 | Unspecified acute conjunctivitis, right eye |
| H10.32 | Unspecified acute conjunctivitis, left eye |
| H10.33 | Unspecified acute conjunctivitis, bilateral |
| 0-9 | A-Z |
|---|---|
| H10.02 | Other mucopurulent conjunctivitis |
| H10.021 | Other mucopurulent conjunctivitis, right eye |
| H10.022 | Other mucopurulent conjunctivitis, left eye |
| H10.023 | Other mucopurulent conjunctivitis, bilateral |
| H10.029 | Other mucopurulent conjunctivitis, unspecified eye |
| H10.3 | Unspecified acute conjunctivitis |
| H10.30 | Unspecified acute conjunctivitis, unspecified eye |
| H10.31 | Unspecified acute conjunctivitis, right eye |
| H10.32 | Unspecified acute conjunctivitis, left eye |
| H10.33 | Unspecified acute conjunctivitis, bilateral |
Formulary Reference Tool